日韩精品久久无码中文字幕,青青草视频下载,一区二区在线观看电影院,一色屋精品视频在线观看

加入收藏 | 設(shè)為首頁(yè) | 聯(lián)系我們

產(chǎn)品搜索

產(chǎn)品分類(lèi)

聯(lián)系我們

聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73001BCR-ABL1/BaF3激酶細(xì)胞

BCR-ABL1/BaF3激酶細(xì)胞
名稱(chēng) BCR-ABL1/BaF3激酶細(xì)胞
型號(hào) CBP73001
報(bào)價(jià)
特點(diǎn) BCR-ABL1/BaF3激酶細(xì)胞,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細(xì)內(nèi)容

CBP73001

I. Introduction

Cell Line Name:

BCR-ABL1/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.

ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.

Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.

The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.

Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.


III. Representative Data

1. WB of  BCR-ABL1/BaF3 expression



2. Sanger of BCR-ABL1/BaF3

Figure 2. BCR-ABL1/BaF3 Fusion

3. Anti-proliferation assay

Figure 3. CTG Proliferation Assay of BaF3 BCR-ABL1 WT Cells (C3).



如果你對(duì)CBP73001BCR-ABL1/BaF3激酶細(xì)胞感興趣,想了解更詳細(xì)的產(chǎn)品信息,填寫(xiě)下表直接與廠家聯(lián)系:


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站
国产精品久久一区二区毛片| 亚洲成a人无码电影网站| 东南亚大奶女BB毛茸茸| 都市激情校园春色丝袜美腿| 美女脱光光污黄网站免费| 亚洲一区二区三区av高清| 99久久精品美女高潮喷水| 99re在线有精品免费| 日韩人妻初体验粉嫩av| 黑人操亚洲女人| a毛片在线还看免费网站| 亚洲欧美综合精品久久成人| 波多野结衣一区二区视频| 丁香婷婷综合激情国产ai| 色5月开心网五月色婷婷| 日韩欧美国产精品一区二区| 中文字幕第一页| 久久这里只有精品最新6| 日韩男手指抠逼黄色视频| 阴筋狠狠插阴道好爽视频| 啊啊啊嗯嗯视频免费轮奸| 成熟老妇女毛茸茸的做性| 美女张开腿让男生桶出水| 欧美色精品人妻在线视频| 欧美日韩精品不卡在线播放| 扒丝袜永久免费网址久久| 初爱视频教程免费观看高清| 中文字幕亚洲欧美无线码| 91制片厂在线观看一二区| caobisesese| 久久久久久A级毛片精品| 呦女1300部真实u女| 亚洲精品久久久久久中文| 日韩紧缚捆绑一区二区三区| 美女高潮白浆视频App| 97精品国产一区二区三区| 黄色大屌操樱桃逼的视频| 伦理片在线观看亚洲一区| 13-15欧美乱婬免费| 老逼操小逼视频| 大鸡巴日B黄色电影网站|